RxDoctor Payments Data

Chelsea Rawding, PA

Physician Assistant · Buffalo, NYNPI 1538673017

Payments from drug & device makers

$546in general payments, 2019–2025

Across 27 payments — averaging $20.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$111
  • Abbott$102
  • Medtronic$100
  • Pfizer$89
  • AbbVie$70
  • Novo Nordisk$30
  • plus $44 from 2 others

What the payments were for

  • Food & beverage$546100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$546 in reported general payments places this provider in the 65th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$32,159
Medicare patients
162
Services billed
430

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin11$54,559
EliquisApixaban35$43,231
XareltoRivaroxaban26$42,429
OzempicSemaglutide25$38,366
JanuviaSitagliptin Phosphate15$20,495
MounjaroTirzepatide15$17,197
JardianceEmpagliflozin16$17,192
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$15,543
Breo ElliptaFluticasone/Vilanterol13$13,315
TrulicityDulaglutide13$11,726
LinzessLinaclotide14$11,404
Esomeprazole Magnesium33$7,130
SynthroidLevothyroxine Sodium61$4,187
Atorvastatin Calcium347$4,073
Diltiazem 12hr ErDiltiazem Hcl13$3,760

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$89$43,23135 claims
Novo NordiskOzempic$30$38,36625 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$111$32,03041 claims
AbbVieLinzess, Synthroid$70$15,59175 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →